| Breakdown | TTM | Jun 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.85M | 78.02M | 11.85M | 30.51M | 8.17M | 8.28M |
| Gross Profit | 3.36M | 23.90M | 3.36M | 11.04M | 2.67M | 3.18M |
| EBITDA | -10.18M | 6.46M | -10.18M | 3.02M | -3.42M | -2.59M |
| Net Income | -10.92M | 2.03M | -10.92M | 69.52K | -5.84M | -5.13M |
Balance Sheet | ||||||
| Total Assets | 30.27M | 87.41M | 30.27M | 26.41M | 24.71M | 22.01M |
| Cash, Cash Equivalents and Short-Term Investments | 2.78M | 9.95M | 2.78M | 2.18M | 5.92M | 5.29M |
| Total Debt | 14.40M | 17.20M | 14.40M | 8.89M | 8.46M | 9.64M |
| Total Liabilities | 18.21M | 60.55M | 18.21M | 16.10M | 14.92M | 11.29M |
| Stockholders Equity | 12.05M | 26.85M | 12.05M | 10.31M | 9.79M | 10.72M |
Cash Flow | ||||||
| Free Cash Flow | -10.29M | -1.05M | -10.29M | -3.29M | -1.32M | -273.11K |
| Operating Cash Flow | -10.07M | -501.30K | -10.07M | 1.70M | 2.19M | 2.84M |
| Investing Cash Flow | -4.77M | -4.98M | -6.00M | -4.99M | -3.51M | -3.11M |
| Financing Cash Flow | 15.32M | 11.70M | 20.35M | -410.19K | 2.86M | 4.64M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £110.42M | 20.87 | 25.90% | 2.00% | 8.19% | ― | |
70 Neutral | £66.93M | 12.03 | 9.07% | ― | 7.36% | 31.93% | |
68 Neutral | £80.84M | 8.13 | 3.91% | 1.56% | 8.75% | -54.73% | |
67 Neutral | £205.83M | 25.56 | 3.10% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | £212.62M | 88.18 | 10.42% | ― | ― | ― | |
54 Neutral | £195.87M | -4.02 | -37.50% | ― | -16.33% | -448.12% |